Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning

Human and Experimental Toxicology

Volumn 16, Issue 8, 1997, Pages 466-472

  Worek, F ^a   Backer M ^a   Thiermann, H ^a   Szinicz, L ^a   Mast, U ^b   Klimmek, R ^b   Eyer, P ^b  

^a Inst fur Pharmakol und Toxikol   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acetylcholinesterase; Erythrocytes; Organophosphates; Oximes; Poisoning; Therapy

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; ACETYLCHOLINESTERASE; CHLORPYRIFOS; CLOFENVINFOS; DIMPYLATE; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; OBIDOXIME; ORGANOPHOSPHATE; OXIME; PARATHION; PRALIDOXIME; SARIN; SOMAN; TABUN;

ARTICLE; CONTINUOUS INFUSION; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ERYTHROCYTE; INTOXICATION; PRIORITY JOURNAL;

EID: 0030881299     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/096032719701600808     Document Type: Article

References (26)

1. Namba T, Hiraki K. PAM (Pyridine-2-aldoxime methiodide) therapy for alkylphosphate poisoning. J Amer Med Assoc 1958; 166: 1834-1839.
2. Erdmann WD, von Clarmann M. Ein neuer Esterase-Reaktivator für die Behandlung von Vergiftungen mit Alkylphosphaten. Dtsch med Wschr 1963; 88: 2201-2206.
3. De Silva HJ, Wijewickrema R, Senanayake N. Does pralidoxime affect outcome of management in acute organophosphate poisoning? Lancet 1992; 339: 1136-1138.
4. Johnson MK, Vale JA, Marrs TC, Meredith TJ. Pralidoxime for organophosphorus poisoning. Lancet 1992; 340: 64.
5. Ellman GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88-95.
6. Van Dongen CJ, Elskamp RM, De Jong LPA. Influence of atropine upon reactivation and ageing of rat and human erythrocyte acetylcholinesterase inhibited by soman. Biochem Pharmacol 1987; 36: 1167-1169.
7. De Jong LPA, Wolring GZ. Effect of 1-(ar)alkyl-2-hydroxyiminomethyl-pyridinium salts on reactivation and ageing of acetylcholinesterase inhibited by ethyl dimethylphosphoramido-cyanidate (tabun). Biochem Pharmacol 1978; 27: 2229-2235.
8. Bülbring E. Observations on the isolated phrenic nerve diaphragm preparation of the rat. Br J Pharmacol 1946; 1: 38-61.
9. Wolthuis OL, Vanwersch RAP, van der Wiel HJ. The efficacy of some bis-pyridinium oximes as antidotes to soman in isolated muscles of several species including man. Europ J Pharmacol 1981; 70: 355-369.
10. Skrinjaric-Spoljar M, Simeon V, Reiner E. Spontaneous reactivation and aging of dimethylphosphorylated acetylcholinesterase and cholinesterase. Biochim Biophys Acta 1973; 315: 363-369.
11. Aldridge WN, Reiner E. Interactions of esterases with esters of organophosphorus and carbamic acids. In: Enzyme Inhibitors as Substrates. North-Holland Publ. Co., Amsterdam, 1972.
12. Wang EIC, Braid PE. Oxime reactivation of diethylphosphoryl human serum cholinesterase. J Biol Chem 1967; 242: 2683-2687.
13. Su C-T et al. Kinetic studies and structure-activity relationships of bispyridinium oximes as reactivators of acetylcholinesterase inhibited by organophosphorus compounds. Fund Appl Toxicol 1986; 6: 506-524.
14. Mast U. Reaktivierung der Erythrozyten-Acetylcholinesterase durch Oxime. Ermittlung enzym-kinetischer Konstanten und ihre Bedeutung für die Therapie einer Organophosphat-Vergiftung. Thesis, München, 1997.
15. Eyer P, Mast U. Pharmacokinetic aspects to improve oxime therapy in OP poisoning. Proc. 2nd Chem Biol Med Treatment Symp. B. Price (ed.) 1997, 88-93.
16. Okonek S. Akute Nitrostigmin-Intoxikation des Menschen. Intensivmedizin 1979; 16: 63-67.
17. Zech R, Erdmann WD, Engelhard H. Grenzen der Therapie mit Oximen bei Vergiftungen mit Insektiziden Alkylphosphaten. Arzneim Forsch 1967; 17: 1196-1202.
18. Kusic R, Boskovic B, Vojvodic V, Jovanovic D. HI-6 in man: blood levels, urinary excretion, and tolerance after intramuscular administration of the oxime to healthy volunteers. Fund Appl Toxicol 1985; 5: S89-S97.
19. Kusic R et al. HI-6 in man: Efficacy of the oxime in poisoning by organophosphorus insecticides. Hum Exp Toxicol 1991; 10: 113-118.
20. Sundwall A. Minimum concentrations of N-methylpyndinium-2-aldoxime methane sulphonate (P2S) which reverse neuromuscular block. Biochem Pharmacol 1961; 8: 413-417.
21. Nenner M. Phosphonylierte Aldoxime. Hemmwirkung auf Acetylcholinesterase und hydrolytischer Abbau. Biochem Pharmacol 1974; 23: 1255-1262.
22. Vale JA. Oximes-useless and harmful? Przeglad Lekarski 1995; 52: 201.
23. Casey PB, Blakey L, Bradberry SM, Vale JA. Late reactivation of erythrocyte cholinesterase activity by pralidoxime in a case of chlorpyrifos poisoning. Przeglad Lekarski 1995; 52: 206.
24. Medicis JJ et al. Pharmacokinetics following a loading plus a continuous infusion of pralidoxime compared with the traditional short infusion regimen in human volunteers. Clin Toxicol 1996; 34: 289-295.
25. Sidell FR, Groff WA. Toxogonin: Blood levels and side effects after intramuscular administration in man. J Pharm Sci 1970; 59: 793-797.
26. Vale JA. Rationale for oxime therapy: pralidoxime as an antidote in OP insecticide poisoning. Hum Exp Toxicol 1996; 15: 77.